2023 Was a tricky 12 months with the biopharma market, with various companies downsizing and restructuring their workforces to stay afloat. You can find indications of Restoration, as mergers and acquisitions picked up over the pharmaceutical and lifetime sciences field in the latter A part of 2023 and have continued https://sites.google.com/view/bio-sites/blog